Heftdal, L. D., Hamm, S. R., Pérez‐Alós, L., Madsen, J. R., Armenteros, J. J. A., Fogh, K., . . . Garred, P. (2023). Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies. European Journal of Haematology, 111(2), 229. https://doi.org/10.1111/ejh.13986
Chicago Style (17th ed.) CitationHeftdal, Line Dam, et al. "Humoral and Cellular Immune Responses After Three or Four Doses of BNT162b2 in Patients with Hematological Malignancies." European Journal of Haematology 111, no. 2 (2023): 229. https://doi.org/10.1111/ejh.13986.
MLA (9th ed.) CitationHeftdal, Line Dam, et al. "Humoral and Cellular Immune Responses After Three or Four Doses of BNT162b2 in Patients with Hematological Malignancies." European Journal of Haematology, vol. 111, no. 2, 2023, p. 229, https://doi.org/10.1111/ejh.13986.